KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Idexx Laboratories (IDXX) Short-term Investments: 2012-2017

Historic Short-term Investments for Idexx Laboratories (IDXX) over the last 6 years, with Dec 2017 value amounting to $284.3 million.

  • Idexx Laboratories' Short-term Investments rose 19.96% to $284.3 million in Q4 2017 from the same period last year, while for Dec 2017 it was $284.3 million, marking a year-over-year increase of 19.96%. This contributed to the annual value of $284.3 million for FY2017, which is 19.96% up from last year.
  • As of FY2017, Idexx Laboratories' Short-term Investments stood at $284.3 million, which was up 19.96% from $236.9 million recorded in FY2016.
  • In the past 5 years, Idexx Laboratories' Short-term Investments ranged from a high of $284.3 million in FY2017 and a low of $1.1 million during FY2013.
  • For the 3-year period, Idexx Laboratories' Short-term Investments averaged around $244.9 million, with its median value being $236.9 million (2016).
  • Data for Idexx Laboratories' Short-term Investments shows a peak YoY surged of 1,859.01% (in 2015) over the last 5 years.
  • Over the past 5 years, Idexx Laboratories' Short-term Investments (Yearly) stood at $1.1 million in 2013, then soared by 910.47% to $10.9 million in 2014, then surged by 1,859.01% to $213.6 million in 2015, then grew by 10.94% to $236.9 million in 2016, then climbed by 19.96% to $284.3 million in 2017.